SLC39A6 Antibody

1. ZIP6 deficiency disturbs intracellular Zn2+ homeostasis, leading to increased cell survival in hypoxia and reduced E-cadherin expression, indicating that decreased ZIP6 expression is strongly associated with resistance to hypoxia. PMID:28833062
2. SLC39A6 promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasis. PMID:28209530
3. Upregulation of SLC39A6 is associated with hepatocellular carcinoma. PMID:26684241
4. SLC39A6 may have a tumor promoting role in esophageal carcinoma PMID:26444413
5. Knock-down of ZIP6 but not ZIP7 in MIN6 beta cells impaired the protective effects of GLP-1 on fatty acid-induced cell apoptosis, possibly via reduced activation of the p-ERK pathway PMID:25969539
6. drug resistance of ovarian cancer cells to trichostatin A may be related to expression of the LIV1 gene PMID:25420545
7. Zinc and its transporters, ZIP6 and ZIP10, are required for the breast cancer cells motility stimulated with high glucose level, such as in diabetes. PMID:24587242
8. a causative role for ZIP6 in cell motility and migration PMID:23919497
9. Down-regulated LIV-1 cells showed significant inhibition of proliferation in vitro and reduction of tumor growth in vivo. Furthermore, E-cadherin expression increased in LIV-1 siRNA expressing Hep-G2. PMID:23437163
10. SLC39A6 has an important role in the prognosis of esophageal squamous-cell carcinoma and may be a potential therapeutic target. PMID:23644492
11. Some studies correlate LIV-1 expression with a more aggressive cancer phenotype and increased likelihood for metastasis to lymph nodes. In contrast, other evidence suggests this transporter is associated with a more favorable prognosis. [review] PMID:22852056
12. The results of this study showed evidence for a positive correlation between LIV1 and ZnT6 insuperior temporal, occipital, and frontal gyri in patient with alzheimer disease. PMID:22349685
13. LIV-1 is involved in prostate cancer progression as an intracellular target of growth factor receptor signaling which promoted EMT and cancer metastasis PMID:22110740
14. LIV-1 mRNA upregulation is associated with the progression of cervical cancer but not with the development of endometrial carcinoma. PMID:17959546
15. The present study identifies LIV1 as a critical mediator responsible for HDACi-induced apoptosis. The effect of LIV1 is, at least in part, mediated by affecting intracellular zinc homeostasis. PMID:19887557
16. Zip6 over-expression is not an underlying mechanism initiating breast cancer, but in fact may play a "tumor-constraining" role. PMID:19852955
17. Structure-function analysis of LIV-1. PMID:12839489
18. data suggest that LIV-1 protein is a promising candidate for a novel marker for breast cancer patients with better outcome PMID:15986450
19. regulation of LIV-1 protein in human breast cancer xenografts PMID:17786585
20. Hence, our data provide the first evidence that LIV-1 mRNA is overexpressed in cervical cancer in situ and is involved in invasion of cervical cancer cells through targeting MAPK-mediated Snail and Slug expression. PMID:17825787
21. LIV-1 may be a regulator of E-cadherin PMID:18330719
22. Single nucleotide polymorphism in SLC39A6 gene is associated with acute lymphoblastic leukemia. PMID:19066393
23. LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells. PMID:19724917
24. LIV-1 co-clusters with estrogen receptor alpha in microarray analysis of breast cancer biopsies. PMID:11911440
25. Review of LIV-1 and other LZT proteins. PMID:12659941
26. LIV-1, a member of the ZIP family of zinc transporters, is an integral plasma membrane protein that transports zinc into cells. PMID:12839489
27. LIV-1 is coregulated with estrogen receptor in some breast cancers. PMID:12960427

Show More

Hide All

HGNC: 18607

UNIGENE: Hs.79136

KEGG: hsa:25800

STRING: 9606.ENSP00000269187

OMIM: 608731